Premium
EyePoint Inc (EYPT)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | Institution | 8 296 375 | 9,90% | US$ 101,71M | 2026-03-31 |
| Cormorant Asset Management, LP | Institution | 8 265 000 | 9,86% | US$ 101,33M | 2026-03-31 |
| BlackRock, Inc. | Institution | 7 177 337 | 8,56% | US$ 87,99M | 2026-03-31 |
| Federated Hermes, Inc. | Institution | 5 669 589 | 6,76% | US$ 69,51M | 2026-03-31 |
| Franklin Resources, Inc. | Institution | 4 997 500 | 5,96% | US$ 61,27M | 2026-03-31 |
| Paradigm BioCapital International Fund Ltd. | Institution | 3 694 542 | 4,41% | US$ 45,30M | 2026-02-17 |
| Janus Henderson Group plc | Institution | 3 601 168 | 4,30% | US$ 44,15M | 2026-03-31 |
| TCG Crossover Fund II, L.P. | Institution | 3 572 335 | 4,26% | US$ 43,80M | 2024-10-31 |
| Vanguard Capital Management, LLC | Institution | 3 559 569 | 4,25% | US$ 43,64M | 2026-03-31 |
| Adage Capital Management, L.P. | Institution | 3 300 000 | 3,94% | US$ 40,46M | 2026-03-31 |
| Adage Capital Partners, L.P. | Institution | 3 300 000 | 3,94% | US$ 40,46M | 2026-03-31 |
| RA Capital Healthcare Fund, L.P. | Institution | 3 181 818 | 3,80% | US$ 39,01M | 2024-12-31 |
| Paradigm Biocapital Advisors LP | Institution | 3 142 437 | 3,75% | US$ 38,53M | 2026-03-31 |
| Commodore Capital LP | Institution | 2 825 000 | 3,37% | US$ 34,63M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 2 097 202 | 2,50% | US$ 25,71M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 1 983 665 | 2,37% | US$ 24,32M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 1 905 875 | 2,27% | US$ 23,37M | 2026-03-31 |
| Aberdeen Group Plc | Institution | 1 738 378 | 2,07% | US$ 21,31M | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 1 438 737 | 1,72% | US$ 17,64M | 2026-03-31 |
| Parkman Healthcare Partners LLC | Institution | 1 354 800 | 1,62% | US$ 16,61M | 2026-03-31 |
| Eventide Asset Management, LLC | Institution | 1 245 583 | 1,49% | US$ 15,27M | 2026-03-31 |
| Essex Woodlands Management, Inc. | Institution | 1 084 857 | 1,29% | US$ 13,30M | 2026-03-31 |
| OrbiMed Advisors LLC | Institution | 1 069 147 | 1,28% | US$ 13,11M | 2026-03-31 |
| 5AM Venture Management, LLC | Institution | 1 050 000 | 1,25% | US$ 12,87M | 2026-03-31 |
| Rosalind Advisors, Inc. | Institution | 1 036 737 | 1,24% | US$ 12,71M | 2026-03-31 |
| Morgan Stanley | Institution | 1 012 760 | 1,21% | US$ 12,42M | 2026-03-31 |
| CHI Advisors LLC | Institution | 912 594 | 1,09% | US$ 11,19M | 2026-03-31 |
| HSBC Global Asset Management (UK) Limited | Institution | 833 455 | 0,99% | US$ 10,22M | 2026-03-31 |
| StemPoint Capital LP | Institution | 810 764 | 0,97% | US$ 9,94M | 2026-03-31 |
| Patient Square Capital, LP | Institution | 795 000 | 0,95% | US$ 9,75M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 793 870 | 0,95% | US$ 9,73M | 2026-03-31 |
| Artia Global Partners LP | Institution | 767 098 | 0,91% | US$ 9,40M | 2026-03-31 |
| Sio Capital Management, LLC | Institution | 721 785 | 0,86% | US$ 8,85M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 676 812 | 0,81% | US$ 8,30M | 2026-03-31 |
| Candriam, Société En Commandite Par Actions | Institution | 674 395 | 0,80% | US$ 8,27M | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | Institution | 640 123 | 0,76% | US$ 7,85M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 551 827 | 0,66% | US$ 6,77M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
